Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,506 | 2,668 | 3,524 | 200 | 159 |
| Marketable Securities | 3,102 | 4,076 | 4,141 | 8,571 | 9,829 |
| Other current assets | 0 | 0 | 0 | 70 | 69 |
| TOTAL | $7,729 | $6,878 | $7,681 | $8,921 | $10,178 |
| Non-Current Assets | |||||
| Intangibles | 247 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 62 | 64 | 65 | 66 | 68 |
| TOTAL | $310 | $64 | $65 | $66 | $68 |
| Total Assets | $8,038 | $6,941 | $7,746 | $8,987 | $10,246 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,251 | 802 | 704 | 607 | 1,048 |
| TOTAL | $1,323 | $874 | $776 | $679 | $1,120 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $758 | $776 | $794 | $812 | $830 |
| Total Liabilities | $2,081 | $1,649 | $1,569 | $1,491 | $1,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,484 | 2,803 | 2,844 | 3,109 | 3,109 |
| Retained earnings | -12,605 | -11,674 | -10,872 | -9,751 | -9,091 |
| Other shareholders' equity | 364 | 440 | -477 | -163 | -19 |
| TOTAL | $5,958 | $5,292 | $6,177 | $7,497 | $8,296 |
| Total Liabilities And Equity | $8,038 | $6,941 | $7,746 | $8,987 | $10,246 |